Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Photoswitchable Flow Cytometry Directly Tracks Single Circulating Tumor Cells

By LabMedica International staff writers
Posted on 22 May 2014
A original method has been developed that allows investigators to label and track single tumor cells circulating in the blood and this advance could help to develop a better understanding of cancer spread and how to stop it.

The innovative method allows for labeling and tracking of individual circulating cancer cells throughout the body, thereby helping scientists to elucidate the pathways of single cells from start to finish, including invasion into nearby normal tissue, movement into the lymphatic system or the bloodstream. More...


An international team led by those at the University of Arkansas for Medical Sciences (Little Rock, AR, USA) used photoswitchable fluorescent proteins that change their color in response to light. When the first laser of light hits the circulating tumor cells, they appear to be fluorescent green. A second laser, using a different wavelength, makes the cells appear to be fluorescent red. To label individual cells, the scientists used a very thin violet laser beam aimed at small blood vessels. The fluorescence from each cell is collected, detected, and reproduced on a computer monitor as real-time signal traces, allowing the investigators to count and track individual cells in the bloodstream.

In tumor-bearing mice, the scientists could monitor the real-time dynamics of circulating cancer cells released from a primary tumor. They could also image the various final destinations of individual circulating cells and observe how these cells circulate and colonize healthy tissue, existing sites of metastasis, or the site of the primary tumor. The Multicolor Photoswitchable Flow Cytometry (PFC) Platform was based on an Olympus IX81 inverted microscope (Olympus America; Center Valley, PA, USA) with incorporated three continuous-wave lasers.

Ekaterina Galanzha, MD, PhD, the senior author of the study said, “This technology allows for the labeling of just one circulating pathological cell among billions of other normal blood cells by ultrafast changing color of photosensitive proteins inside the cell in response to laser light. Therefore, the approach may give oncologists knowledge on how to intervene and stop circulating cancer cell dissemination that might prevent the development of metastasis.” The study was published on May 8, 2014, in the journal Chemistry & Biology.

Related Links:

University of Arkansas for Medical Sciences
Olympus America  



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Rapid Flu Test
Influenza A&B Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.